As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
Executive Leadership Assessment plays a key role in private equity investments, serving as a important determinant of organizational effectiveness and the success or failure of…
Read moreFunds need to squeeze more free cash flow from companies in order to generate an adequate return from vintage 2019-2022 investments. More sales growth and/or…
Read moreThe fund landscape is changing faster than ever before, creating winners and losers in an increasingly competitive private equity ecosystem. Higher real interest rates are…
Read moreReceive our news and valuable perspectives on organizational effectiveness each month.